IL217745D0 - Antiviral compounds and methods of making and using thereof - Google Patents

Antiviral compounds and methods of making and using thereof

Info

Publication number
IL217745D0
IL217745D0 IL217745A IL21774512A IL217745D0 IL 217745 D0 IL217745 D0 IL 217745D0 IL 217745 A IL217745 A IL 217745A IL 21774512 A IL21774512 A IL 21774512A IL 217745 D0 IL217745 D0 IL 217745D0
Authority
IL
Israel
Prior art keywords
making
methods
antiviral compounds
antiviral
compounds
Prior art date
Application number
IL217745A
Original Assignee
Versitech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US23143109P priority Critical
Priority to PCT/CN2010/001187 priority patent/WO2011015037A1/en
Application filed by Versitech Ltd filed Critical Versitech Ltd
Publication of IL217745D0 publication Critical patent/IL217745D0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/422Oxazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
IL217745A 2009-08-05 2012-01-26 Antiviral compounds and methods of making and using thereof IL217745D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US23143109P true 2009-08-05 2009-08-05
PCT/CN2010/001187 WO2011015037A1 (en) 2009-08-05 2010-08-05 Antiviral compounds and methods of making and using there of cross reference to related applications

Publications (1)

Publication Number Publication Date
IL217745D0 true IL217745D0 (en) 2012-03-29

Family

ID=43543887

Family Applications (1)

Application Number Title Priority Date Filing Date
IL217745A IL217745D0 (en) 2009-08-05 2012-01-26 Antiviral compounds and methods of making and using thereof

Country Status (13)

Country Link
EP (1) EP2462138B1 (en)
JP (1) JP2013501008A (en)
KR (1) KR20120092567A (en)
CN (1) CN102596946B (en)
AU (1) AU2010281265A1 (en)
BR (1) BR112012002331A2 (en)
CA (1) CA2770140A1 (en)
IL (1) IL217745D0 (en)
IN (1) IN2012DN01254A (en)
MX (1) MX2012001504A (en)
RU (1) RU2012104214A (en)
SG (1) SG178106A1 (en)
WO (1) WO2011015037A1 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0918249D0 (en) 2009-10-19 2009-12-02 Respivert Ltd Compounds
UY33337A (en) 2010-10-18 2011-10-31 Respivert Ltd A substituted 1H-pyrazolo [3,4-d] pyrimidine compounds as inhibitors of phosphoinositide 3-KINASE
WO2011147198A1 (en) * 2010-05-28 2011-12-01 Versitech Limited Compounds and methods for treatment of proliferative diseases
MX2013002557A (en) * 2010-09-08 2013-05-28 Squibb Bristol Myers Co Novel piperazine analogs as broad-spectrum influenza antivirals.
ES2564257T3 (en) * 2010-09-28 2016-03-21 Bristol-Myers Squibb Company New piperazine analogues with substituted heteroaryl groups as broad-spectrum influenza antivirals
WO2012088266A2 (en) 2010-12-22 2012-06-28 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
GB201104267D0 (en) 2011-03-14 2011-04-27 Cancer Rec Tech Ltd Pyrrolopyridineamino derivatives
WO2012134967A2 (en) * 2011-03-25 2012-10-04 Bristol-Myers Squibb Company Three-dimensional structure of hin1 nucleoprotein in complex with antiviral compounds
KR101369584B1 (en) * 2011-04-19 2014-03-06 일양약품주식회사 Phenyl-isoxazol derivatives and preparation process thereof
CN102432555A (en) * 2011-09-09 2012-05-02 中国科学院广州生物医药与健康研究院 1, 2, 3-triazole-4 (5) carboxamide compound and application thereof
ES2600705T3 (en) 2012-03-13 2017-02-10 Respivert Limited Crystal PI3 Kinase Inhibitors
ES2657942T3 (en) * 2012-05-18 2018-03-07 Vironova Influenza Ab Methanethione compounds that have antiviral activity
US9676734B2 (en) 2012-05-18 2017-06-13 Vironova Influenza Ab Compounds and methods
NZ743274A (en) 2012-06-13 2019-07-26 Incyte Holdings Corp Substituted tricyclic compounds as fgfr inhibitors
US9388185B2 (en) 2012-08-10 2016-07-12 Incyte Holdings Corporation Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
GB201216018D0 (en) 2012-09-07 2012-10-24 Cancer Rec Tech Ltd Pharmacologically active compounds
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
AR095353A1 (en) 2013-03-15 2015-10-07 Respivert Ltd Compound
TW201522341A (en) 2013-03-15 2015-06-16 Respivert Ltd Compound
CN109912594A (en) 2013-04-19 2019-06-21 因赛特控股公司 Bicyclic heterocycle as FGFR inhibitor
KR20160037171A (en) 2013-07-30 2016-04-05 얀센 사이언시즈 아일랜드 유씨 Substituted pyridine-piperazinyl analogues as rsv antiviral compounds
GB201314452D0 (en) 2013-08-13 2013-09-25 Ostara Biomedical Ltd Embryo implantation
GB201415569D0 (en) 2014-09-03 2014-10-15 C4X Discovery Ltd Therapeutic Compounds
GB201501302D0 (en) 2015-01-27 2015-03-11 Ostara Biomedical Ltd Embryo implantation
EP3617205A1 (en) 2015-02-20 2020-03-04 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
WO2016134294A1 (en) 2015-02-20 2016-08-25 Incyte Corporation Bicyclic heterocycles as fgfr4 inhibitors
EA201791867A1 (en) 2015-02-20 2017-12-29 Инсайт Корпорейшн Bicyclic heterocycles as fgfr4 inhibitors
GB201517523D0 (en) 2015-10-05 2015-11-18 Ostara Biomedical Ltd Methods and compositions for managing reproduction
CN107056762B (en) * 2016-12-22 2020-08-28 四川百利药业有限责任公司 Bis-carbonyl analogues for use against influenza virus
WO2018141854A1 (en) 2017-02-02 2018-08-09 Janssen Vaccines & Prevention B.V. Piperazine derivatives for influenza virus inhibition
AR111960A1 (en) 2017-05-26 2019-09-04 Incyte Corp crystalline forms of an inhibitor of FGFR and processes for their preparation
TW201920143A (en) 2017-08-23 2019-06-01 瑞士商諾華公司 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05117150A (en) * 1991-10-25 1993-05-14 Sanwa Kagaku Kenkyusho Co Ltd Antiviral agent
WO2003089177A1 (en) * 2002-04-18 2003-10-30 Lee Bum Jeon Oxygen cutter hose
DE10236564A1 (en) * 2002-08-08 2004-05-19 Ursapharm Arzneimittel Gmbh & Co. Kg Use of papaverine-like vasodilator and pharmaceutical composition
NZ560712A (en) * 2005-02-17 2010-12-24 Synta Pharmaceuticals Corp (3,4,5-trisubstituted-phenyl)isoxazole combretastin derivatives for the treatment of disorders
US8642660B2 (en) * 2007-12-21 2014-02-04 The University Of Rochester Method for altering the lifespan of eukaryotic organisms

Also Published As

Publication number Publication date
KR20120092567A (en) 2012-08-21
EP2462138A4 (en) 2013-01-23
SG178106A1 (en) 2012-03-29
CN102596946B (en) 2015-06-17
EP2462138A1 (en) 2012-06-13
RU2012104214A (en) 2013-09-10
AU2010281265A1 (en) 2012-03-22
CA2770140A1 (en) 2011-02-10
CN102596946A (en) 2012-07-18
EP2462138B1 (en) 2014-09-24
BR112012002331A2 (en) 2019-09-24
MX2012001504A (en) 2012-06-01
IN2012DN01254A (en) 2015-05-15
JP2013501008A (en) 2013-01-10
AU2010281265A2 (en) 2012-04-05
WO2011015037A1 (en) 2011-02-10

Similar Documents

Publication Publication Date Title
HRP20180157T1 (en) Pyrazolopyrimidine jak inhibitor compounds and methods
IL237581A (en) Derivatives of 6-oxo-pyrazinopyrrolopyrimidines
NO20191224A1 (en) Svellbare polymerer med hydrofobe grupper
HRP20161330T1 (en) Therapeutic compounds and related methods of use
HK1179608A1 (en) Forms of rifaximin and uses thereof
ZA201303499B (en) Specific diarylhydantoin and diarylthiohydantion compounds
HK1173197A1 (en) Primary production of elements
IL246900D0 (en) Polymorphs of darunavir
HRP20151037T1 (en) Piceatannol-containing composition and method of producing piceatannol-containing composition
IL217370D0 (en) Novel nucleic acid prodrugs and methods of use thereof
HK1172896A1 (en) Compounds and methods of use
HRP20170936T1 (en) Alkylamido compounds and uses thereof
HK1215038A1 (en) Anti-il-17f antibodies and methods of use thereof il-17f
ZA201208770B (en) New forms of rifaximin and uses thereof
IL219884D0 (en) Formulations of antibody
HK1178149A1 (en) Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use -4---
HK1161094A1 (en) Compounds and methods of use
EP2520259A4 (en) Diaper
EP2536303A4 (en) Electronic hookah
PL2501666T3 (en) Method to purify and stabilize chloroolefins
HK1247911A1 (en) Multicyclic compounds and methods of use thereof
EP2473054A4 (en) Compositions and methods for treatment of leukemia
GB0919432D0 (en) Use
EP2485771A4 (en) Phosphodiesterase 1-targeting tracers and methods
GB2467610B (en) Elevator and method of use